Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients

References

• Ammassari , A. , Antinori , A. , Aloisi , M.S. , Trotta , M.P. , Murri , R. Bartoli , L. 2004 . Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons . Psychosomatics , 45 : 394 – 402 .
   PubMed Web of Science ®Google Scholar
• Beck , A.T. , Rush , A.J. , Shaw , B.F. and Emery , G. 1979 . Cognitive Therapy of Depression , New York : Guilford Press .
   Google Scholar
• Bianchi , G. , Loguercio , C. , Sgarbi , D. , Abbiati , R. , Chen , C.H. Di Pierro , M. 2000 . Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment . Digestive and Liver Disease , 32 : 398 – 405 .
   Web of Science ®Google Scholar
• Bonaccorso , S. , Puzella , A. , Marino , V. , Pasquini , M. , Biondi , M. Artini , M. 2001 . Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms . Psychiatry Research , 105 : 45 – 55 .
   PubMed Web of Science ®Google Scholar
• Cohen , M. , Hoffman , R.G. , Cromwell , C. , Schmeidler , J. , Ebrahim , F. Carrera , G. 2002 . The prevalence of distress in persons with human immunodeficiency virus infection . Psychosomatics , 43 : 10 – 15 .
   PubMed Web of Science ®Google Scholar
• Dimatteo , M.R. , Lepper , H.S. and Croghan , T.W. 2000 . Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effect of anxiety and depression on patient adherence . Archives of Internal Medicine , 160 : 2101 – 107 .
   PubMed Web of Science ®Google Scholar
• Fleming , C.A. , Christiansen , D. , Nunes , D. , Heeren , T. , Thornton , D. Horsburgh , C.R. Jr . 2004 . Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection . Clinical Infectious Diseases , 38 : 572 – 78 .
   PubMed Web of Science ®Google Scholar
• Fried , M.W. 2002 . Side effects of therapy for hepatitis C and their management . Hepatology , 36 ( Suppl 1 ) : S237 – 244 .
   PubMed Web of Science ®Google Scholar
• Fried , M.W. , Shiffman , M.L. , Reddy , K.R. , Smith , C. , Marinos , G. Goncales , F. L Jr . 2002 . Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection . The New England Journal of Medicine , 347 : 975 – 82 .
   PubMed Web of Science ®Google Scholar
• Hauser , P. , Khosla , J. , Aurora , H. , Laurin , J. , Kling , M.A. Hill , J. 2002 . A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C . Molecular Psychiatry , 7 : 942 – 47 .
   PubMed Web of Science ®Google Scholar
• Hsiung , P.C. , Fang , C.T. , Chang , Y.Y. , Chen , M.Y. and Wang , J.D. 2005 . Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection . Quality of Life Research , 14 : 141 – 50 .
   PubMed Web of Science ®Google Scholar
• Johnson , M.O. , Stallworth , T. and Neilands , T.B. 2003 . The drugs or the disease?. Causal attributions of symptoms held by HIV-positive adults on HAART . AIDS and Behavior , 7 : 109 – 17 .
   PubMed Web of Science ®Google Scholar
• Kraus , M.R. , Schafer , A. , Csef , H. , Faller , H. , Mork. , H. and Scheurlen , M. 2001 . Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition . Digestive Diseases and Science , 46 : 2060 – 65 .
   PubMed Web of Science ®Google Scholar
• Laguno , M. , Blanch , J. , Murillas , J. , Blanco , J.L. , Leon , A. Lonca , M. 2004 . Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C . Antiviral Therapy , 9 : 905 – 909 .
   PubMed Web of Science ®Google Scholar
• Laguno , M. , Murillas , J. , Blanco , J.L. , Martinez , E. , Miquel , R. Sanchez-Tapias , J.M. 2004 . Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients . AIDS , 18 : 27 – 36 .
   Web of Science ®Google Scholar
• Lucas , G.M. , Chaisson , R.E. and Moore , R.D. 1999 . Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions . Annals of Internal Medicine , 131 : 81 – 87 .
   PubMed Web of Science ®Google Scholar
• Manns , M.P. , McHutchison , J.G. , Gordon , S.C. , Rustgi , V.K. , Shiffman , M. Reindollar , R. 2001 . Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial . Lancet , 358 : 958 – 65 .
   PubMed Web of Science ®Google Scholar
• Moreno , L. , Quereda , C. , Moreno , A. , Perez-Elias , M.J. , Antela , A. Casado , J.L. 2004 . Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients . AIDS , 18 : 67 – 73 .
   PubMed Web of Science ®Google Scholar
• Musselman , D.L. , Lawson , D.H. , Gumnick , J.F. , Manatunga , A.K. , Penna , S. Goodkin , R.S. 2001 . Paroxetine for the prevention of depression induced by high-dose interferon alfa . New England Journal of Medicine , 344 : 961 – 66 .
   PubMed Web of Science ®Google Scholar
• Myers , R.P. , Benhamou , Y. , Bochet , M. , Thibault , V. , Mehri , D. and Poynard , T. 2004 . Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-coinfected non-responders and relapsers to IFN-based therapy . AIDS , 18 : 75 – 79 .
   PubMed Web of Science ®Google Scholar
• Paterson , D.L. , Swindells , S. , Mohr , J. , Brester , M. , Vergis , E.N. Squier , C. 2000 . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection . Annals of Internal Medicine , 133 : 21 – 30 .
   PubMed Web of Science ®Google Scholar
• Pérez-Olmeda , M. , Núñez , M. , Romero , M. , Gonzalez , J. , Castro , A. Arribas , Jr. 2003 . Pegylated IFN-a 2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients . AIDS , 17 : 1023 – 28 .
   PubMed Web of Science ®Google Scholar
• Phillips , K.D. , Sowell , R.L. , Rojas , M. , Tavakoli , A. , Fulk , L.J. and Hand , G.A. 2004 . Physiological and psychological correlates of fatigue in HIV disease . Biological Research for Nursing , 6 : 59 – 74 .
   PubMedGoogle Scholar
• Russo , M.W. and Fried , M.W. 2003 . Side effects of therapy for chronic hepatitis C . Gastroenterology , 124 : 1711 – 719 .
   PubMed Web of Science ®Google Scholar
• Schaefer , M. , Schmidt , F. , Folwaczny , C. , Lorenz , R. , Martin , G. Schindlbeck , N. 2003 . Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups . Hepatology , 37 : 443 – 51 .
   PubMed Web of Science ®Google Scholar
• Sherman , K.E. 2004 . HCV and HIV: a tale of two viruses . Reviews in gastroenterological disorders , 4 ( Suppl 1 ) : 48 – 54 .
   Google Scholar
• Starace , F. , Ammassari , A. , Trotta , M.P. , Murri , R. , De Longis , P. Izzo , C. 2002 . Depression is a risk factor for supoptimal adherence to highly active antiretroviral therapy . Journal of Acquired Immune Deficiency Syndromes , 31 ( Suppl 3 ) : S136 – S139 .
   PubMed Web of Science ®Google Scholar
• Torriani , F.J. , Rodriguez-Torres , M. , Rockstroh , J.K. , Lissen , E. , Gonzalez-Garcia , J. Lazzarin , A. 2004 . Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients . New England Journal of Medicine , 351 : 438 – 50 .
   PubMed Web of Science ®Google Scholar
• Tuldra , A. , Fumaz , C.R. , Ferrer , M.J. , Bayes , R. , Arno , A. Balague , M. 2000 . Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy . Journal of Acquired Immune Deficiency Syndromes , 25 : 221 – 28 .
   PubMed Web of Science ®Google Scholar
• Vázquez , C. and Sanz , J. 2000 . “ Adaptación española del Inventario de Depresión de Beck (1978): propiedades psicométricas y clínicas en muestras clínicas y en población general ” . In Medición clínica en psiquiatría y psicología , Edited by: Bulbena , A. , Berrios , G. and Fernández de Larrinoa , P. 291 – 93 . Barcelona : Masson S.A .
   Google Scholar
• Ware , J. J and Sherbourne , C.D. 1992 . The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection . Medical Care , 30 : 473 – 83 .
   PubMed Web of Science ®Google Scholar